MLTX logo

MoonLake Immunotherapeutics (MLTX) EV/EBITDA

EV/EBITDA

-27.45
+0.66+2.35%

Fri, 29 Nov 2024 19:13:06 GMT

MLTX EV/EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MLTX EV/EBITDA Performance

PeriodPeriodEV/EBITDAEV/EBITDA
todaytoday+2.4%
1 m1 month-11.7%
3 m3 months+18.7%
6 m6 months+18.8%
ytdytd+53.6%
1 y1 year+30.8%
5 y5 years-

MLTX EV/EBITDA High & Low

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1 month-23.55-16.6%-28.16+2.5%
3 m3 months-23.43-17.2%-40.25+31.8%
6 m6 months-23.43-17.2%-40.25+31.8%
1 y1 year-23.43-17.2%-63.12+56.5%
3 y3 years-2.54-980.7%-63.12+56.5%
5 y5 years-2.54-980.7%-63.12+56.5%
alltimeall time-2.54-980.7%-63.12+56.5%

MoonLake Immunotherapeutics EV/EBITDA History

DateValue
2024
-27.45(-53.6%)
DateValue
2023
-59.22(+895.3%)
2022
-5.95

FAQ

  • What is MoonLake Immunotherapeutics EV/EBITDA?
  • What is the all time high EV/EBITDA for MoonLake Immunotherapeutics?
  • What is MLTX EV/EBITDA year-to-date change?
  • What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?

What is MoonLake Immunotherapeutics EV/EBITDA?

The current EV/EBITDA of MLTX is -27.45

What is the all time high EV/EBITDA for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high EV/EBITDA is -2.54

What is MLTX EV/EBITDA year-to-date change?

MoonLake Immunotherapeutics EV/EBITDA has changed by +31.77 (+53.65%) since the beginning of the year

What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?

Over the past year, MLTX EV/EBITDA has changed by +12.20 (+30.77%)